A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

NCT04535544 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis D, Chronic

Interventions

DRUG: JNJ-73763989
DRUG: Placebo
DRUG: Entecavir (ETV) monohydrate
DRUG: Tenofovir disoproxil
DRUG: Tenofovir alafenamide (TAF)

Sponsor

Janssen Research & Development, LLC